Healthcare provider profile · identity verified

Manjula Kandaa Raman, MD

Internal Medicine · POTTSTOWN, PA · NPI 1275533390

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1124	312
Levothyroxine Sodium	Levothyroxine Sodium	612	147
Lisinopril	Lisinopril	582	157
Amlodipine Besylate	Amlodipine Besylate	548	155
Losartan Potassium	Losartan Potassium	391	106
Metformin Hcl	Metformin Hcl	367	104
Gabapentin	Gabapentin	337	81
Pantoprazole Sodium	Pantoprazole Sodium	336	82
Metoprolol Succinate	Metoprolol Succinate	292	85
Rosuvastatin Calcium	Rosuvastatin Calcium	244	82
Hydrochlorothiazide	Hydrochlorothiazide	230	66
Famotidine	Famotidine	213	69
Furosemide	Furosemide	213	57
Omeprazole	Omeprazole	200	60
Montelukast Sodium	Montelukast Sodium	185	59
Fluticasone Propionate	Fluticasone Propionate	184	55
Allopurinol	Allopurinol	178	49
Glimepiride	Glimepiride	172	52
Metoprolol Tartrate	Metoprolol Tartrate	163	47
Clopidogrel	Clopidogrel Bisulfate	157	44
Oxybutynin Chloride	Oxybutynin Chloride	156	32
Eliquis	Apixaban	155	29
Albuterol Sulfate Hfa	Albuterol Sulfate	154	51
Buspirone Hcl	Buspirone Hcl	131	26
Simvastatin	Simvastatin	130	38
Januvia	Sitagliptin Phosphate	129	33
Mirtazapine	Mirtazapine	125	29
Jardiance	Empagliflozin	122	24
Hydralazine Hcl	Hydralazine Hcl	119	24
Tramadol Hcl	Tramadol Hcl	118	30
Prednisone	Prednisone	115	79
Tamsulosin Hcl	Tamsulosin Hcl	111	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	109	33
Sertraline Hcl	Sertraline Hcl	109	30
Atenolol	Atenolol	108	26
Ezetimibe	Ezetimibe	108	36
Trazodone Hcl	Trazodone Hcl	105	27
Potassium Chloride	Potassium Chloride	103	25
Duloxetine Hcl	Duloxetine Hcl	96	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	28
Carvedilol	Carvedilol	84	26
Valsartan	Valsartan	83	27
Escitalopram Oxalate	Escitalopram Oxalate	79	19
Tizanidine Hcl	Tizanidine Hcl	78	21
Spironolactone	Spironolactone	75	18
Alprazolam	Alprazolam	72	15
Meloxicam	Meloxicam	69	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	69	51
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	suppressed
Meclizine Hcl	Meclizine Hcl	58	23
Lorazepam	Lorazepam	57	15
Citalopram Hbr	Citalopram Hydrobromide	56	14
Azithromycin	Azithromycin	54	48
Pioglitazone Hcl	Pioglitazone Hcl	52	16
Amoxicillin	Amoxicillin	51	21
Fenofibrate	Fenofibrate	51	16
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	51	14
Amitriptyline Hcl	Amitriptyline Hcl	50	suppressed
Topiramate	Topiramate	49	suppressed
Ropinirole Hcl	Ropinirole Hcl	47	12
Pregabalin	Pregabalin	46	suppressed
Donepezil Hcl	Donepezil Hcl	44	11
Methylprednisolone	Methylprednisolone	44	36
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Bupropion Xl	Bupropion Hcl	43	13
Breo Ellipta	Fluticasone/Vilanterol	42	13
Metformin Hcl Er	Metformin Hcl	42	11
Trulicity	Dulaglutide	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	13
Paroxetine Hcl	Paroxetine Hcl	38	13
Xarelto	Rivaroxaban	37	suppressed
Nystatin	Nystatin	35	20
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	34	suppressed
Glipizide	Glipizide	34	suppressed
Bumetanide	Bumetanide	32	suppressed
Cefuroxime	Cefuroxime Axetil	31	28
Clonazepam	Clonazepam	31	suppressed
Diazepam	Diazepam	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Incruse Ellipta	Umeclidinium Bromide	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	15
Synthroid	Levothyroxine Sodium	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	13
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	12
Farxiga	Dapagliflozin Propanediol	25	suppressed
Ozempic	Semaglutide	25	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Finasteride	Finasteride	24	suppressed
Fluconazole	Fluconazole	24	19
Myrbetriq	Mirabegron	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Sucralfate	Sucralfate	24	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	20
Levetiracetam	Levetiracetam	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Lactulose	Lactulose	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Digoxin	Digoxin	15	suppressed
Dulera	Mometasone/Formoterol	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	14	suppressed
Estradiol	Estradiol	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Austedo	Deutetrabenazine	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nadolol	Nadolol	12	suppressed
Nyamyc	Nystatin	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error